These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7509598)
41. Spackling the crack: stabilizing human fibroblast growth factor-1 by targeting the N and C terminus beta-strand interactions. Dubey VK; Lee J; Somasundaram T; Blaber S; Blaber M J Mol Biol; 2007 Aug; 371(1):256-68. PubMed ID: 17570396 [TBL] [Abstract][Full Text] [Related]
42. Biochemical properties of C78SC96S rhFGF-2: a double point-mutated rhFGF-2 increases obviously its activity. Wang J; Hong A; Ren JS; Sun FY; Shi YJ; Liu K; Xie QL; Dai Y; Li ZY; Chen Y J Biotechnol; 2006 Feb; 121(4):442-7. PubMed ID: 16223539 [TBL] [Abstract][Full Text] [Related]
43. 1H NMR structural characterization of a nonmitogenic, vasodilatory, ischemia-protector and neuromodulatory acidic fibroblast growth factor. Lozano RM; Pineda-Lucena A; Gonzalez C; Angeles Jiménez M; Cuevas P; Redondo-Horcajo M; Sanz JM; Rico M; Giménez-Gallego G Biochemistry; 2000 May; 39(17):4982-93. PubMed ID: 10819962 [TBL] [Abstract][Full Text] [Related]
44. Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals. Arese M; Chen Y; Florkiewicz RZ; Gualandris A; Shen B; Rifkin DB Mol Biol Cell; 1999 May; 10(5):1429-44. PubMed ID: 10233154 [TBL] [Abstract][Full Text] [Related]
45. FGF-2 dimerization involvement in growth factor mediated cell proliferation but not cell differentiation. Van den Berghe L; Mortier I; Zanibellato C; Amalric F; Prats H; Bugler B Biochem Biophys Res Commun; 1998 Nov; 252(2):420-7. PubMed ID: 9826545 [TBL] [Abstract][Full Text] [Related]
46. Studies on FGF-2: nuclear localization and function of high molecular weight forms and receptor binding in the absence of heparin. Rifkin DB; Moscatelli D; Roghani M; Nagano Y; Quarto N; Klein S; Bikfalvi A Mol Reprod Dev; 1994 Sep; 39(1):102-4; discussion 104-5. PubMed ID: 7999354 [TBL] [Abstract][Full Text] [Related]
47. Keratinocyte growth factor as a mitogen for primary culture of rat hepatocytes. Itoh T; Suzuki M; Mitsui Y Biochem Biophys Res Commun; 1993 May; 192(3):1011-5. PubMed ID: 7685158 [TBL] [Abstract][Full Text] [Related]
48. Translokin is an intracellular mediator of FGF-2 trafficking. Bossard C; Laurell H; Van den Berghe L; Meunier S; Zanibellato C; Prats H Nat Cell Biol; 2003 May; 5(5):433-9. PubMed ID: 12717444 [TBL] [Abstract][Full Text] [Related]
49. Phosphatidylinositol-3 kinase-dependent activation of Akt does not correlate with either high mitogenicity or cell migration induced by FGF-1. Marcinkowska E; Wiedlocha A Anticancer Res; 2003; 23(5A):4071-7. PubMed ID: 14666721 [TBL] [Abstract][Full Text] [Related]
50. Fibroblast growth factor-1 induction of delayed-early mRNA expression in NIH 3T3 cells is prolonged by heparin addition. Donohue PJ; Hsu DK; Guo Y; Burgess WH; Winkles JA Exp Cell Res; 1997 Jul; 234(1):139-46. PubMed ID: 9223379 [TBL] [Abstract][Full Text] [Related]
51. Production and functional characterization of human recombinant FGF-6 protein. Pizette S; Batoz M; Prats H; Birnbaum D; Coulier F Cell Growth Differ; 1991 Nov; 2(11):561-6. PubMed ID: 1814436 [TBL] [Abstract][Full Text] [Related]
53. Introduction of a chemical constraint in a short peptide derived from human acidic fibroblast growth factor elicits mitogenic structural determinants. Kiyota S; Franzoni L; Nicastro G; Benedetti A; Oyama S; Viviani W; Gambarini AG; Spisni A; Miranda MT J Med Chem; 2003 Jun; 46(12):2325-33. PubMed ID: 12773037 [TBL] [Abstract][Full Text] [Related]
54. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain. Yang CQ; Zhan X; Hu X; Kondepudi A; Perdue JF Endocrinology; 1996 Jul; 137(7):2766-73. PubMed ID: 8770896 [TBL] [Abstract][Full Text] [Related]
56. Effect of low pH and heparin on the structure of acidic fibroblast growth factor. Pineda-Lucena A; Núñez De Castro I; Lozano RM; Muñoz-Willery I; Zazo M; Giménez-Gallego G Eur J Biochem; 1994 Jun; 222(2):425-31. PubMed ID: 7517355 [TBL] [Abstract][Full Text] [Related]
57. The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues. Jackson A; Tarantini F; Gamble S; Friedman S; Maciag T J Biol Chem; 1995 Jan; 270(1):33-6. PubMed ID: 7529229 [TBL] [Abstract][Full Text] [Related]
58. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity. Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766 [TBL] [Abstract][Full Text] [Related]
59. Structural requirements of FGF-1 for receptor binding and translocation into cells. Zakrzewska M; Krowarsch D; Wiedlocha A; Olsnes S; Otlewski J Biochemistry; 2006 Dec; 45(51):15338-48. PubMed ID: 17176056 [TBL] [Abstract][Full Text] [Related]
60. Secretion of FGF-16 requires an uncleaved bipartite signal sequence. Miyakawa K; Imamura T J Biol Chem; 2003 Sep; 278(37):35718-24. PubMed ID: 12851399 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]